Association of serum PAPP‐A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta‐analysis
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Objectives: To determine association, and predictive ability, of first trimester maternal serum pregnancy associated plasma protein A (PAPP‐A) with adverse pregnancy outcomes. Method: Searches of Medline, Embase and CINAHL (inception September 2015) for studies including pregnant women with first trimester PAPP‐A and assessment of pregnancy outcomes. Study characteristics, quality and results extracted. Meta‐analysis of odds ratios (ORs), and likelihood ratios (LRs) and 95% confidence intervals (CI). Results: Thirty‐two studies including 175 240 pregnancies. PAPP‐A <5th centile had a moderate association with: birth weight <10th centile OR 2.08 (95% CI 1.89–2.29), <5th centile OR 2.83 (95% CI 2.52–3.18); pre‐eclampsia OR 1.94 (95% CI 1.63–2.30), preterm birth <37 weeks OR 2.09 (95% CI 1.87–2.33), and composite adverse outcome OR 3.31 (95% CI 1.80–5.11). The predictive ability was poor: Birth weight <10th centile LR + ve 1.96 (95% CI 1.58–2.43), LR‐ve 0.93 (95% CI 0.89–0.98); birth weight <5th centile LR + ve 2.65 (95% CI 2.35–2.99), LR‐ve 0.85 (95% CI 0.74–0.98); PTB <37 weeks LR + ve 1.84 (95% CI 1.41–2.39), LR‐ve 0.92 (95% CI 0.87–0.98). Conclusions: First trimester low maternal serum PAPP‐A is associated with adverse pregnancy outcome, but predictive values are poor. Further work should address PAPP‐A as a continuous variable in combination with other prognostic markers as a prediction model. © 2016 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369
Dichotomizing continuous predictors in multiple regression: a bad idea
Royston, P., Altman, D. G., & Sauerbrei, W. (2006) · Statistics in Medicine · doi:10.1002/sim.2331 · Cited by 2,312
Meta-analysis of individual participant data: rationale, conduct, and reporting
Riley, R. D., Lambert, P. C., & Abo-Zaid, G. (2010) · BMJ · doi:10.1136/bmj.c221 · Cited by 1,701 · cited 1×
“One technique to overcome this is individual patient data meta-analysis, which uses original source data at the participant level, thus having many advantages such as being able to derive prognostic factor results directly, independent of study reporting and significance, and analyse continuous factors more appropriat…”
MethodPrognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
Steyerberg, E. W., Moons, K. G. M., van der Windt, D. A., Hayden, J. A., Perel, P., Schroter, S., Riley, R. D., Hemingway, H., Altman, D. G., & for the PROGRESS Group (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001381 · Cited by 1,508 · cited 1×
“Any prognostic model developed would then require validation in external data sets.(74) At present in the UK practice, PAPP-A is only used as part of combined screening for Down syndrome and not as a biomarker for adverse outcome.”
MethodPepe, M. S. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh101 · Cited by 1,276
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
Riley, R. D., Hayden, J. A., Steyerberg, E. W., Moons, K. G. M., Abrams, K., Kyzas, P. A., Malats, N., Briggs, A., Schroter, S., Altman, D. G., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001380 · Cited by 823 · cited 2×
“If treatments are available that may modify disease then prognostic factors may have a role in predicting differential treatment response.(68) Even if a prognostic factor is insufficient as a stand-alone test, it may still add some independent prognostic value over other prognostic factors, and used in a multivariable…”
Background
Cited by
Poon, L. C., Shennan, A., Hyett, J. A., Kapur, A., Hadar, E., Divakar, H., McAuliffe, F., da Silva Costa, F., von Dadelszen, P., McIntyre, H. D., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12802 · Cited by 1,238
Melamed, N., Baschat, A., Yinon, Y., Athanasiadis, A., Mecacci, F., Figueras, F., Berghella, V., Nazareth, A., Tahlak, M., McIntyre, H. D., et al. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13522 · Cited by 570
Neonatal Morbidities of Fetal Growth Restriction: Pathophysiology and Impact
Malhotra, A., Allison, B. J., Castillo-Melendez, M., Jenkin, G., Polglase, G. R., & Miller, S. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00055 · Cited by 453
“Accordingly, low levels of PAPP-A in early pregnancy are linked with an increased risk for FGR, although the predictive value of this biomarker still remains poor (15).”
BackgroundMcCowan, L. M., Figueras, F., & Anderson, N. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.004 · Cited by 451
Gestational Hypertension and Preeclampsia: An Overview of National and International Guidelines
Tsakiridis, I., Giouleka, S., Arvanitaki, A., Giannakoulas, G., Papazisis, G., Mamopoulos, A., Athanasiadis, A., & Dagklis, T. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000942 · Cited by 64
Fetal growth restriction and stillbirth: Biomarkers for identifying at risk fetuses
King, V. J., Bennet, L., Stone, P. R., Clark, A., Gunn, A. J., & Dhillon, S. K. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.959750 · Cited by 52
Metadata
- Authors
- Morris, R. K., Bilagi, A., Devani, P., & Kilby, M. D.
- Venue
- Prenatal Diagnosis
- Publisher
- Wiley
- Published
- 2017-02-17
- Volume
- 37
- Issue
- 3
- Pages
- 253-265
- ISSN
- 0197-3851 (ISSN-L)
- 1097-0223
- OpenAlex
- W2565146302
- Cited by
- 123
- References
- 15
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.